SCHEMBL16178342

SCHEMBL16178342

Nc1nc(F)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CF)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.63
PNP P00491 1/20 0.63
TP53 P04637 1/20 0.63
HTT P42858 1/20 0.63
PDE4D Q08499 1/20 0.63
PDE3A Q14432 1/20 0.63
SMN1; SMN2 Q16637 1/20 0.63
RXFP1 Q9HBX9 1/20 0.63
AHCY P23526 4/20 0.59
NT5E P21589 3/20 0.56
HIF1A Q16665 1/20 0.56
CA5A P35218 1/20 0.52
ADORA3 P0DMS8 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA2B P29275 1/20 0.47
ADORA1 P30542 1/20 0.47
ADRB1 P08588 1/20 0.46
DNMT1 P26358 1/20 0.46
POLB P06746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16178343 1.00 LMNA (0.63) LMNAPNPTP53HTTPDE4D
SCHEMBL15623873 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL976990 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL5982283 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL976991 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL23982169 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL5982273 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL1470361 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL5790133 0.91 LMNA (0.76) LMNAPNPTP53HTTPDE4D
SCHEMBL23897428 0.85 AHCY (0.63) LMNAPNPTP53HTTPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9402925-B2 Probes and methods of imaging a bacterial infection THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIO (US) 2016-08-02 US disclosed
US-20140314671-A1 PROBES AND METHODS OF IMAGING A BACTERIAL INFECTION THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2014-10-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140314671-A1 PROBES AND METHODS OF IMAGING A BACTERIAL INFECTION MPI, MGAM, TREH LMNA 3943/4885PNP 695/4885TP53 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.